Stay updated on Nivolumab Plus Ipilimumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added. Revision: v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-21T08:31:17.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Updated the site revision tag from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T18:43:03.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page shows a minor revision update from v3.4.1 to v3.4.2, with no visible changes to study content or eligibility details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:47:47.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision: v3.4.1 updated from v3.4.0; no user-facing study details or functionality appear to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T09:23:08.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Minor metadata update: Revision v3.3.4 was added and the previous Revision v3.3.3 was removed; this does not affect study content or user-facing details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T10:40:50.000Z thumbnail image
  9. Check
    113 days ago
    Change Detected
    Summary
    Added Location sections listing sites in Arkansas, Connecticut, Florida, Georgia, Missouri, New York, Ohio, South Carolina, Tennessee, Hainaut (Belgium), and Cluj (Romania); removed the previous location blocks, and updated the revision to v3.3.3.
    Difference
    1.0%
    Check dated 2025-12-17T20:00:37.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page.